Hemogenyx Pharmaceuticals PLC (HEMO) — Tangible Net Worth Ratio
Hemogenyx Pharmaceuticals PLC (HEMO) has a Tangible Net Worth Ratio of 44.1% as of December 2024. This metric is calculated by deducting intangible assets (GBX477.40K) from net assets (GBX853.49K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Hemogenyx Pharmaceuticals PLC (HEMO) net assets for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Hemogenyx Pharmaceuticals PLC Tangible Net Worth Ratio (2015–2024)
This chart shows how Hemogenyx Pharmaceuticals PLC's Tangible Net Worth Ratio has changed across 9 annual periods from 2015 to 2024. As of December 2024, the ratio stands at 44.1%, reflecting net assets of GBX853.49K with intangible assets of GBX477.40K GBX. Also explore Hemogenyx Pharmaceuticals PLC annual equity growth to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Hemogenyx Pharmaceuticals PLC (2015–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Hemogenyx Pharmaceuticals PLC from 2015 to 2024, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market cap of Hemogenyx Pharmaceuticals PLC.
| Year | Tangible NW Ratio | Net Assets (GBX) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 44.1% | GBX853.49K | GBX477.40K | GBX4.21 Million | ▼ -39.0 pp |
| 2023 | 83.1% | GBX2.78 Million | GBX470.17K | GBX6.11 Million | ▼ -3.3 pp |
| 2022 | 86.4% | GBX3.24 Million | GBX441.49K | GBX7.09 Million | ▼ -8.2 pp |
| 2021 | 94.6% | GBX8.17 Million | GBX441.49K | GBX8.52 Million | ▲ +23.7 pp |
| 2020 | 70.9% | GBX875.68K | GBX254.96K | GBX2.66 Million | ▼ -0.7 pp |
| 2018 | 71.6% | GBX959.17K | GBX272.75K | GBX2.30 Million | ▼ -16.4 pp |
| 2017 | 87.9% | GBX2.13 Million | GBX257.52K | GBX2.40 Million | ▲ +19.1 pp |
| 2016 | 68.8% | GBX903.71K | GBX281.58K | GBX1.05 Million | ▲ +271.6 pp |
| 2015 | -202.8% | GBX77.82K | GBX235.64K | GBX324.65K | — |